| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,023,000 | 2,952,000 | 2,810,000 | 3,108,000 | | Cost of Revenue | (3,511,000) | 1,786,000 | 1,725,000 | 1,972,000 | | | Gross Profit | 6,534,000 | 1,166,000 | 1,085,000 | 1,136,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,706,000 | 323,000 | 337,000 | 382,000 | | Non Recurring | 2,000 | 7,000 | 87,000 | (2,000) | | Others | 301,000 | 302,000 | 289,000 | 297,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 525,000 | 534,000 | 372,000 | 459,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,000 | 3,000 | 4,000 | 6,000 | | Earnings Before Interest And Taxes | 529,000 | 537,000 | 376,000 | 457,000 | | Interest Expense | 104,000 | 107,000 | 105,000 | 114,000 | | Income Before Tax | 425,000 | 430,000 | 271,000 | 343,000 | | Income Tax Expense | 133,000 | 163,000 | 101,000 | 125,000 | | Minority Interest | 35,000 | (35,000) |
-
| (8,000) | | | | Net Income From Continuing Ops | 327,000 | 232,000 | 170,000 | 218,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 327,000 | 232,000 | 170,000 | 218,000 | | Preferred Stock And Other Adjustments | (50,000) | 15,000 | (15,000) |
-
| | | Net Income Applicable To Common Shares | $277,000 | $247,000 | $155,000 | $218,000 |
|
2.03% Nasdaq 0.00%
Income Statement
